Antiglycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice

Molecular Nutrition and Food Research

Volumn 52, Issue 11, 2008, Pages 1358-1364

  Lin, Chun Che ^a   Yin, Mei Chin ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aldose reductase; Glycation; s Ethyl cysteine; s Propyl cysteine; VEGF

Indexed keywords

ANTIDIABETIC AGENT; ARGININE; CREATININE; CYSTEINE; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; PENTOSIDINE; S ETHYLCYSTEINE; S PROPYLCYSTEINE; S-ETHYLCYSTEINE; S-PROPYLCYSTEINE; VASCULOTROPIN A;

ALBUMINURIA; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; KIDNEY; MALE; METABOLISM; MOUSE; ORGAN SIZE; PATHOPHYSIOLOGY; URINE;

ALBUMINURIA; ANIMALS; ARGININE; BLOOD GLUCOSE; CREATININE; CYSTEINE; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; KIDNEY; LYSINE; MALE; MICE; MICE, INBRED BALB C; ORGAN SIZE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 55949130901     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800007     Document Type: Article

References (33)

1. Ziyadeh, F. N., Mogyorosi, A., Kalluri, R., Early and advanced non-enzymatic glycation products in the pathogenesis of diabetic kidney disease, Exp. Nephrol. 1997, 5, 2-9.
2. Dunlop, M., Aldose reductase and the role of the polyol pathway in diabetic nephropathy, Kidney Int. 2000, 58, 3-12.
3. Gugliucci, A., Bendayan, M., Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells, Diabetologia 1997, 39, 149-160.
4. Schleicher, E. D., Wagner, E., Nerlich, A. G., Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging, J. Clin. Invest. 1997, 99, 457-468.
5. Cohen, M. P., Chen, S., Ziyadeh, F. N., Shea, E., et al., Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy, Kidney Int. 2005, 68, 1554-1561.
6. Tsuchida, K., Makita, Z., Yamagishi, S., Atsumi, T., et al., Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195, Diabetologia 1999, 42, 579-588.
7. Cheung, A. K., Fung, M. K., Lo, A. C., Lam, T. T., et al., Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice, Diabetes 2005, 54, 3119-3125.
8. Maekawa, K., Tanimoto, T., Okada, S., Suzuki, T., et al., Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated from rat: Effects of high glucose and osmotic stress, Brain Res. Mol. Brain Res. 2001, 87, 251-256.
9. Mizisin, A. P., Li, L., Perello, M., Freshwater, J. D., et al., Polyol pathway and osmoregulation in JS1 Schwann cells grown in hyperglycemic and hyperosmotic conditions, Am. J. Physiol. 1996, 270, 90-97.
10. Thornalley, P. J., Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation, Biochem. Soc. Trans. 2003, 31, 1343-1348.
11. Fukushima, S., Takada, N., Hori, T., Wanibuchi, H., Cancer prevention by organosulfur compounds from garlic and onion, J. Cell. Biochem. 1997, 27, 100-105.
12. Jones, M. G., Hughes, J., Tregova, A., Milne, J., et al., Biosynthesis of the flavour precursors of onion and garlic, J. Exp. Bot. 2004, 55, 1903-1918.
13. Hsu, C. C., Yen, H. F., Yin, M. C., Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice, J. Nutr. 2004, 134, 3245-3249.
14. Yin, M. C., Hsu, C. C., Chiang, P. F., Wu, W. J., Anti-inflammatory and anti-fibrogenic effects of s-ethyl cysteine and smethyl cysteine in kidney of diabetic mice, Mol. Nutr. Food Res. 2007, 51, 572-579.
15. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Protein determination with the Folin phenol reagent, J. Biol. Chem. 1951, 193, 265-275.
16. Inagi, R., Yamamoto, Y., Nangaku, M., Usuda, N., et al., A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice, Diabetes 2006, 55, 356-366.
17. Miyata, T., Taneda, S., Kawai, R., Ueda, Y,. et al., Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis, Proc. Natl. Acad. Sci. USA 1996, 93, 2353-2358.
18. Nishinaka, T., Yabe-Nishimura, C., EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress, Free Radic. Biol. Med. 2001, 31, 205-216.
19. Ulrich, H. B., Methods of Enzymatic Analysis, 2nd Ed., Verlag Chemie, Weinheim 1974, pp 569-573.
20. McLellan, A. C., Thornalley, P. J., Glyoxalase activity in human red blood cells fractioned by age, Mech. Aging Dev. 1989, 48, 63-71.
21. Guerrant, G., Moss, C. W., Determination of monosaccharides as aldononitrile, O-methyoxime, alditol, and cyclitol acetate derivatives by gas chromatography, Anal. Chem. 1984, 56, 633-638.
22. Dan, Q., Wong, R. L. C., Yin, S., Chung, S. K., et al., Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression, Nephron Exp. Nephrol. 2004, 98, 89-99.
23. Staniszewska, M. M., Nagaraj, R. H., Upregulation of glyoxalase I fails to normalize methylglyoxal levels: A possible mechanism for biochemical changes in diabetic mouse lenses, Mol. Cell. Biochem. 2006, 288, 29-36.
24. Haas, C. S., Campean, V., Kuhlmann, A., Dimmler, A., et al., Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis, Virchows. Arch. 2007, 450, 81-92.
25. Kedziora-Kornatowska, K., Szram, S., Kornatowski, T., Szadujkis-Szadurski, L., et al., Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney, Nephron. Exp. Nephrol. 2003, 95, 134-143.
26. Melhem, M. F., Craven, P. A., Derubertis, F. R., Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus, J. Am. Soc. Nephrol. 2001, 12, 124-133.
27. Ou, C. C., Tsao, S. M., Lin, M. C., Yin, M. C., Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic, Lipids 2003, 38, 219-224.
28. Huang, C. C., Yin, M. C., Antioxidative and antiglycative effects of six organosulfur compounds in LDL and plasma, J. Agri Food Chem. 2004, 52, 3674-3678.
29. Cameron, N. E., Cotter, M. A., Basso, M., Hohman, T. C., Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats, Diabetologia 1997, 40, 271-281.
30. Ii, S., Ohta, M., Kudo, E., Yamaoka, T., et al., Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency, Diabetologia 2004, 47, 541-548.
31. Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P. et al., Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis, J. Clin. Invest. 1998, 101, 1142-1147.
32. Vander Jagt, D. L., Hassebrook, R. K., Hunsaker, L. A., Brown, W. M., Royer, R. E., Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: Roles for glutathione in both enzymes and implications for diabetic complications, Chem. Biol. Interact. 2001, 130, 549-562.
33. Cha, D. R., Kang, Y. S., Han, S. Y., Jee, Y. H., et al., Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats, J. Endocrinol. 2004, 183, 183-194.